Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1997
08/14/1997WO1997029124A1 Vitamin d response element binding protein
08/14/1997WO1997029123A2 Nucleic acid encoding gai gene of arabidopsis thaliana
08/14/1997WO1997029120A1 Sarcocystine isolation
08/14/1997WO1997029119A1 Fhit proteins and nucleic acids and methods based thereon
08/14/1997WO1997028824A1 Obesity protein compounds and formulations thereof
08/14/1997WO1997028821A1 Immunological methods for the treatment of gastrointestinal cancer
08/14/1997WO1997028820A1 Vaccines against varicella zoster virus gene 63 product
08/14/1997WO1997028819A1 Vaccine against hantavirus
08/14/1997WO1997028698A1 Ice crystal growth inhibiting agents
08/14/1997WO1997028688A1 Intracellular vitamin d binding protein
08/14/1997WO1997022694A3 Diagnostic reagents relating to diabetes
08/14/1997DE19704979A1 Retroviral vector for expressing interleukin-6 antagonist in human haematopoietic stem cells
08/14/1997DE19605175A1 Lipidverbindungen und deren Verwendung Lipid compounds and their use
08/14/1997DE19605126A1 Thrombinmuteine als Antidot für Thrombininhibitoren Thrombin muteins as an antidote for thrombin inhibitors
08/14/1997DE19605105A1 Neue Sonde zur Früherkennung von epithelialen Dysplasien des mehrschichtigen Plattenepithels sowie zur Tumordiagnostik und Tumortherapie von Plattenepithelkarzinomen New probe for early detection of epithelial dysplasia of the stratified squamous epithelium as well as for tumor diagnosis and tumor therapy of squamous cell carcinoma
08/14/1997CA2733866A1 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
08/14/1997CA2539273A1 A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof
08/14/1997CA2245960A1 Vitamin d response element binding protein
08/14/1997CA2245806A1 Estrogen response element binding proteins and nucleotides encoding therefor
08/14/1997CA2245783A1 Fhit proteins and nucleic acids and methods based thereon
08/14/1997CA2245681A1 Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
08/14/1997CA2245650A1 Intracellular vitamin d binding protein
08/14/1997CA2245546A1 Thrombin muteins as antidotes for thrombin inhibitors
08/14/1997CA2245170A1 Methods and compositions for transforming dendritic cells and activating t cells
08/14/1997CA2244911A1 Synthesis of vip analog
08/14/1997CA2244792A1 Recombinant phages
08/14/1997CA2243718A1 Diabetes therapy
08/13/1997EP0789078A2 Engineered peptide synthetases and their use for the non-ribosomal production of peptides
08/13/1997EP0789077A1 Viral material and nucleotide fragments associated with multiple sclerose having diagnostic, prophylactic and therapeutical uses
08/13/1997EP0789076A2 G protein coupled receptor proteins, their production and use
08/13/1997EP0789031A2 Acellular vaccine
08/13/1997EP0789030A1 Fibrinogen binding peptides
08/13/1997EP0788745A1 Ice crystal growth inhibitor
08/13/1997EP0788557A1 Rapid detection and identification of nucleic acid variants and pathogens
08/13/1997EP0788556A1 New polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms
08/13/1997EP0788555A1 Methods of analysis and manipulation of dna utilizing mismatch repair systems
08/13/1997EP0788547A2 Purified coprinus laccases and nucleic acids encoding same
08/13/1997EP0788546A1 Nematode-extracted serine protease inhibitors and anticoagulant proteins
08/13/1997EP0788545A2 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
08/13/1997EP0788544A2 Recombinant dna
08/13/1997EP0788543A1 Alk-7 (activin like kinase), a serine threonine kinase receptor
08/13/1997EP0788540A1 Human abh
08/13/1997EP0788515A1 Non-antigenic branched polymer conjugates
08/13/1997EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
08/13/1997EP0788513A1 Binding agents to cd23
08/13/1997EP0788512A1 Proinsulin peptide compounds for detecting and treating type i diabetes
08/13/1997EP0788509A1 Therapeutic peptide derivatives
08/13/1997EP0788382A2 Cellular attachment to trans-epithelial appliances
08/13/1997EP0788372A1 Attenuated canine parvovirus vaccine
08/13/1997EP0788371A1 Analgesic method with dynorphin analogues truncated at the n-terminus
08/13/1997EP0788367A1 Stretch-activated cation channel and antisense oligonucleotides thereto
08/13/1997EP0788307A1 Oligonucleotide modulation of multidrug resistance-associated protein
08/13/1997EP0528955B1 Protease deficient bacterial hosts
08/13/1997EP0458937B1 Variants of pai-2
08/13/1997CN1157024A Pumping device
08/13/1997CN1156967A Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby
08/13/1997CN1156966A Polynucleotide vaccine for papillomavirus
08/13/1997CN1156965A Cytokine regulatory agents and method of use in pathologies and conditions associated with altered cytokine levels
08/13/1997CN1156964A Novel Peptides
08/13/1997CN1156726A Process for purifying bactericidal power/permeability increasing protein from big blood
08/13/1997CN1035628C Method for producing monoclonal antibodies
08/13/1997CA2197408A1 Mutant human growth hormones and their uses
08/12/1997USRE35585 DNA vector with isolated cDNA gene encoding metallopanstimulin
08/12/1997US5656749 Nucleic acids encoding receptors for bombesin-like peptides
08/12/1997US5656738 Inducible defensin peptide from mammalian epithelia
08/12/1997US5656737 Dna sequence coding for specified amino acid sequence
08/12/1997US5656732 Polypeptides of feline T-cell lymphotrophic lentivirus
08/12/1997US5656729 Using a chelating chromatography carrier
08/12/1997US5656728 Genetic engineering
08/12/1997US5656725 Stabilize inappropriate cell proliferation or cell death
08/12/1997US5656724 Chemokine-like proteins and methods of use
08/12/1997US5656723 Analogues of hypocalcemiant polypeptide compounds sparing the calcium of the organism, their preparation, their use as medicaments and the compositions containing them
08/12/1997US5656722 A21 -, B30 - modified insulin derivatives having an altered action profile
08/12/1997US5656721 Having sugar moiety; prolonged duration of action
08/12/1997US5656610 Injection into tongue muscle
08/12/1997US5656600 Modified polypeptides
08/12/1997US5656599 Administering e2 trans-activation repressor fusion protein to treat papilloma virus infection
08/12/1997US5656598 Use of fibroblast growth factors to stimulate bone growth
08/12/1997US5656596 Using a polypeptide
08/12/1997US5656595 Culture product; exchange with protin p21-guanosine diphosphate complex
08/12/1997US5656593 Morphogen induced periodontal tissue regeneration
08/12/1997US5656592 Use of relaxin as an analgesic and palliative for intractable pain
08/12/1997US5656591 Antimicrobial agents and method for treating products therewith
08/12/1997US5656589 Using actin binding protein
08/12/1997US5656587 Promotion of cell proliferation by use of transforming growth factor beta (TGF-β)
08/12/1997US5656496 Dark and light regulated chlorophyll A/B Binding Protein Promoter/Regulatory System
08/12/1997US5656488 Recombinant avirulent salmonella antifertility vaccines
08/12/1997US5656485 Eimeria antigenic composition which elicits antibodies against avian coccidiosis
08/12/1997US5656484 Genetic engineering
08/12/1997US5656481 Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules
08/12/1997US5656480 Compounds which inhibit HIV replication
08/12/1997US5656477 Purified, isolated polynucleotide encoding mutein, for cloning protease to detect alzheimer' disease
08/12/1997US5656471 Mutant
08/12/1997US5656466 Process for preparing virus-resistant transgenic plant
08/12/1997US5656458 Expression and processing of amino terminus acetylated FGF's in yeast
08/12/1997US5656457 DNA sequence for the unique sequence herpes simplex virus type 2-glycoprotein G protein and method of expressing said unique sequence of HSV-2gG
08/12/1997US5656456 Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof
08/12/1997US5656455 Adenylate cyclase stimulating factor
08/12/1997US5656454 Endothelial cell-specific enhancer
08/12/1997US5656452 Culturing the cell containing dna comprising 20 nucleotides, permitting the expression of dna